On February 22, 2021 Molecular Partners AG (SIX: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, reported that its Chief Executive Officer, Patrick Amstutz, Ph.D., will present at or attend several upcoming virtual healthcare investor events in February and March, 2021 (Press release, Molecular Partners, FEB 22, 2021, View Source(SIX%3A%20MOLN,investor%20events%20in%20February%20and [SID1234575390]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Presentation Details:
Event: Leerink 10th Annual Global Healthcare Conference
Date/Time: Thursday, February 25, 8:40 AM – 9:10 AM ET (2:40 PM – 3:10 PM CET)
Event: Cowen 41st Annual Health Care Conference
Date/Time: Tuesday, March 2, 2021, 10:30 AM – 11:00 AM ET (4:30 PM – 5:00 PM CET)
Event: H.C. Wainwright Global Life Sciences Conference
Date/Time: Tuesday, March 9, 2021 7:00 AM – 7:30 AM ET (1:00 PM – 1:30 PM CET)
Conference Participation Details:
Event: Credit Suisse Global Virtual Healthcare Conference
Date: March 2-4, 2021
All webcasted presentations will be made available on the Molecular Partners website.